ArticlePloS one2017

Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.

Chao-Bin He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.